AI-generated analysis. Always verify with the original filing.
Madrigal Pharmaceuticals, Inc. issued a press release on February 19, 2026, announcing results of operations and financial condition. The filing includes Exhibit 99.1, the press release dated February 19, 2026.
Event Type
Disclosure
Mandatory
Variant
8-K
Results of Operations and Financial Condition. On February 19, 2026, Madrigal Pharmaceuticals, Inc. (the “Company”) issued a press release announcing the Compan
Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press Release Dated February 19, 2026 104 Cover Page Interactive Data File (embe